Christopher Mason
Direktor/Vorstandsmitglied bei KRYSTAL BIOTECH, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Christopher Mason
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Direktor/Vorstandsmitglied | 04.01.2021 | - |
Independent Dir/Board Member | 04.01.2021 | - | |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.09.2015 | - |
Gründer | 01.09.2015 | - | |
London Regenerative Medicine Network Ltd. | Direktor/Vorstandsmitglied | 01.02.2008 | - |
Gründer | 01.02.2008 | - | |
University College London | Corporate Officer/Principal | - | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Direktor/Vorstandsmitglied | 01.10.2021 | - |
Karriereverlauf von Christopher Mason
Ehemalige bekannte Positionen von Christopher Mason
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AVROBIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 | 30.06.2022 |
Gründer | 01.07.2015 | 30.06.2022 | |
Stem Cell Translation Ltd. | Direktor/Vorstandsmitglied | 01.10.2006 | 01.03.2018 |
Gründer | 01.10.2006 | 01.03.2018 | |
The British Neurological Research Trust | Direktor/Vorstandsmitglied | 01.05.2012 | 01.05.2016 |
UK Stem Cell Foundation | Direktor/Vorstandsmitglied | 01.09.2010 | 01.05.2016 |
Ausbildung von Christopher Mason
King's College London | Doctorate Degree |
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 9 |
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 8 |
Founder | 5 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AVROBIO, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. | |
The British Neurological Research Trust | |
UK Stem Cell Foundation | Miscellaneous |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
- Börse
- Insiders
- Christopher Mason
- Erfahrung